Open AccessSystematic review and meta‐analysis: Multi‐strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events
Author(s) -
McFarland Lynne V,
Huang Ying,
Wang Lin,
Malfertheiner Peter
Publication year - 2016
Publication title -
ueg journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.667
H-Index - 35
eISSN - 2050-6414
pISSN - 2050-6406
DOI - 10.1177/2050640615617358
Subject(s) - medicine , adverse effect , probiotic , helicobacter pylori , diarrhea , meta analysis , antibiotic associated diarrhea , randomized controlled trial , incidence (geometry) , bifidobacterium animalis , lactobacillus acidophilus , gastroenterology , antibiotics , bifidobacterium , microbiology and biotechnology , lactobacillus , clostridium difficile , bacteria , genetics , physics , optics , biology
Background Eradication rates with triple therapy for Helicobacter pylori infections have currently declined to unacceptable levels worldwide. Newer quadruple therapies are burdened with a high rate of adverse events. Whether multi‐strain probiotics can improve eradication rates or diminish adverse events remains uncertain. Methods Relevant publications in which patients with H. pylori infections were randomized to a multi‐strain probiotic or control were identified in PubMed, Cochrane Databases, and other sources from 1 January 1960–3 June 2015. Primary outcomes included eradication rates, incidence of any adverse event and the incidence of antibiotic‐associated diarrhea. As probiotic efficacy is strain‐specific, pooled relative risks and 95% confidence intervals were calculated using meta‐analysis stratified by similar multi‐strain probiotic mixtures. Results A total of 19 randomized controlled trials (20 treatment arms, n = 2730) assessing one of six mixtures of strains of probiotics were included. Four multi‐strain probiotics significantly improved H. pylori eradication rates, five significantly prevented any adverse reactions and three significantly reduced antibiotic‐associated diarrhea. Only two probiotic mixtures ( Lactobacillus acidophilus / Bifidobacterium animalis and an eight‐strain mixture) had significant efficacy for all three outcomes. Conclusions Our meta‐analysis found adjunctive use of some multi‐strain probiotics may improve H. pylori eradication rates and prevent the development of adverse events and antibiotic‐associated diarrhea, but not all mixtures were effective.